Treatment Options to Explore When Serum Uric Acid Targets Are Not Attained

Share this content:

Machelle Manuel, PhD, discusses further gout treatment options to consider when target serum urate levels are not attained.


Machelle Manuel, PhD, is vice president, Medical Scientific Affairs, at Ironwood Pharmaceuticals, the manufacturer of lesinurad.

You must be a registered member of Rheumatology Advisor to post a comment.

Upcoming Meetings

Sign Up for Free e-newsletters